Alumis (ALMS) Common Equity (2023 - 2025)
Alumis' (ALMS) quarterly Common Equity came in at $301.3 million in Q4 2025, up 15.84% year-on-year from $260.1 million in Q4 2024, and down 21.69% on a QoQ basis from $384.8 million in Q3 2025.
Alumis (ALMS) Common Equity (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Common Equity data on file, last reported at $301.3 million in Q4 2025.
- On a quarterly basis, Common Equity rose 15.84% year-over-year to $301.3 million in Q4 2025; TTM through Dec 2025 was $301.3 million, a 15.84% increase from a year earlier, with the FY2025 full-year figure at $301.3 million, up 15.84% from the prior year.
- Common Equity for Q4 2025 stood at $301.3 million, down from $384.8 million in the prior quarter.
- Over the last five years, Common Equity for ALMS reached as high as $485.3 million in Q2 2025 and fell as low as -$438.8 million in Q2 2024.
- Historically, Common Equity has averaged $19.9 million across 3 years, with a median of $168.3 million in 2025.
- On a YoY basis, Common Equity climbed as much as 214.95% in 2024 and fell as far as 67.24% in 2024.
- Year by year, Common Equity stood at -$339.3 million in 2023, then jumped by 176.67% to $260.1 million in 2024, then climbed by 15.84% to $301.3 million in 2025.
- Per Business Quant data, the three most recent Common Equity figures were $301.3 million in Q4 2025, $384.8 million in Q3 2025, and $485.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 251.12 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -98.34 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.76 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.36 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 19.36 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 31.42 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.79 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.50 Bn |
| 10 | Alumis | 2.41 Bn | 2.10 Bn | - | 301.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 301.30 Mn |
| Sep 30, 2025 | 384.77 Mn |
| Jun 30, 2025 | 485.33 Mn |
| Mar 31, 2025 | 168.31 Mn |
| Dec 31, 2024 | 260.10 Mn |
| Sep 30, 2024 | 348.39 Mn |
| Jun 30, 2024 | -438.76 Mn |
| Mar 31, 2024 | -385.93 Mn |
| Dec 31, 2023 | -339.26 Mn |
| Sep 30, 2023 | -303.07 Mn |
| Jun 30, 2023 | -262.35 Mn |